Table of Contents
ISRN Neurology
Volume 2011 (2011), Article ID 732879, 6 pages
http://dx.doi.org/10.5402/2011/732879
Research Article

Serine 129 Phosphorylation of α-Synuclein Cross-Links with Tissue Transglutaminase to Form Lewy Body-Like Inclusion Bodies

1Department of Neurology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China
2Dpartment of Neurology, The First People's Hospital of Foshan, Foshan 528000, China
3Department of Pathophysiology, School of Medicine, JiNan University, Guangzhou 510632, China
4Center for Inherited Cardiovascular Disease, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA 94304, USA

Received 28 January 2011; Accepted 16 March 2011

Academic Editor: T. B. Sherer

Copyright © 2011 Wei Bi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Baba, S. Nakajo, P. H. Tu et al., “Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies,” American Journal of Pathology, vol. 152, no. 4, pp. 879–884, 1998. View at Google Scholar · View at Scopus
  2. J. Xu, C. Wei, C. Xu et al., “Rifampicin protects PC12 cells against MPP-induced apoptosis and inhibits the expression of an α-Synuclein multimer,” Brain Research, vol. 1139, no. 1, pp. 220–225, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. E. A. Waxman and B. I. Giasson, “Specificity and regulation of casein kinase-mediated phosphorylation of α-synuclein,” Journal of Neuropathology and Experimental Neurology, vol. 67, no. 5, pp. 402–416, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Schell, T. Hasegawa, M. Neumann, and P. J. Kahle, “Nuclear and neuritic distribution of serine-129 phosphorylated α-synuclein in transgenic mice,” Neuroscience, vol. 160, no. 4, pp. 796–804, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. W. W. Smith, R. L. Margolis, X. Li et al., “α-synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells,” Journal of Neuroscience, vol. 25, no. 23, pp. 5544–5552, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Sugeno, A. Takeda, T. Hasegawa et al., “Serine 129 phosphorylation of α-synuclein induces unfolded protein response-mediated cell death,” Journal of Biological Chemistry, vol. 283, no. 34, pp. 23179–23188, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Lee, M. Tanaka, K. Park et al., “Casein kinase II-mediated phosphorylation regulates α-synuclein/synphilin-1 interaction and inclusion body formation,” Journal of Biological Chemistry, vol. 279, no. 8, pp. 6834–6839, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Hand, M. J. M. Perry, and L. W. Haynes, “Cellular transglutaminases in neural development,” International Journal of Developmental Neuroscience, vol. 11, no. 6, pp. 709–720, 1993. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Monsonego, T. Mizrahi, S. Eitan et al., “Factor XIIIa as a nerve-associated transglutaminase,” FASEB Journal, vol. 12, no. 12, pp. 1163–1171, 1998. View at Google Scholar · View at Scopus
  10. L. Fesus and M. Piacentini, “Transglutaminase 2: an enigmatic enzyme with diverse functions,” Trends in Biochemical Sciences, vol. 27, no. 10, pp. 534–539, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Lorand and R. M. Graham, “Transglutaminases: crosslinking enzymes with pleiotropic functions,” Nature Reviews Molecular Cell Biology, vol. 4, no. 2, pp. 140–156, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Fesus and M. Piacentini, “Transglutaminase 2: an enigmatic enzyme with diverse functions,” Trends in Biochemical Sciences, vol. 27, no. 10, pp. 534–539, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Byrne, C. Feighery, J. Jackson, and J. Kelly, “Coeliac disease autoantibodies mediate significant inhibition of tissue transglutaminase,” Clinical Immunology, vol. 136, no. 3, pp. 426–431, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. M. M. M. Wilhelmus, A. M. van Dam, and B. Drukarch, “Tissue transglutaminase: a novel pharmacological target in preventing toxic protein aggregation in neurodegenerative diseases,” European Journal of Pharmacology, vol. 585, no. 2-3, pp. 464–472, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Sugeno, A. Takeda, T. Hasegawa et al., “Serine 129 phosphorylation of α-synuclein induces unfolded protein response-mediated cell death,” Journal of Biological Chemistry, vol. 283, no. 34, pp. 23179–23188, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Junn, R. D. Ronchetti, M. M. Quezado, S. Y. Kim, and M. M. Mouradian, “Tissue transglutaminase-induced aggregation of α-synuclein: implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 4, pp. 2047–2052, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Rodolfo, E. Mormone, P. Matarrese et al., “Tissue transglutaminase is a multifunctional BH3-only protein,” Journal of Biological Chemistry, vol. 279, no. 52, pp. 54783–54792, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. K. K. Dev, K. Hofele, S. Barbieri, V. L. Buchman, and H. Van Der Putten, “Part II: α-synuclein and its molecular pathophysiological role in neurodegenerative disease,” Neuropharmacology, vol. 45, no. 1, pp. 14–44, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Fujiwara, M. Hasegawa, N. Dohmae et al., “α-synuclein is phosphorylated in synucleinopathy lesions,” Nature Cell Biology, vol. 4, no. 2, pp. 160–164, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. P. J. Kahle, M. Neumann, L. Ozmen et al., “Hyperphosphorylation and insolubility of α-synuclein in transgenic mouse oligodendrocytes,” EMBO Reports, vol. 3, no. 6, pp. 583–588, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. J. P. Anderson, D. E. Walker, J. M. Goldstein et al., “Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic lewy body disease,” Journal of Biological Chemistry, vol. 281, no. 40, pp. 29739–29752, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Arawaka, M. Wada, S. Goto et al., “The role of G-protein-coupled receptor kinase 5 in pathogenesis of sporadic Parkinson's disease,” Journal of Neuroscience, vol. 26, no. 36, pp. 9227–9238, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. LI. Chen and M. B. Feany, “α-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease,” Nature Neuroscience, vol. 8, no. 5, pp. 657–663, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Andringa, K. Y. Lam, M. Chegary, X. Wang, T. N. Chase, and M. C. Bennett, “Tissue transglutaminase catalyzes the formation of alpha-synuclein crosslinks in Parkinson's disease,” The FASEB Journal, vol. 18, no. 7, pp. 932–934, 2004. View at Google Scholar · View at Scopus
  25. S. Kanda, J. F. Bishop, M. A. Eglitis, Y. Yang, and M. M. Mouradian, “Enhanced vulnerability to oxidative stress by α-synuclein mutations and C-terminal truncation,” Neuroscience, vol. 97, no. 2, pp. 279–284, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Zourlidou, M. D. Payne Smith, and D. S. Latchman, “Modulation of cell death by α-synuclein is stimulus-dependent in mammalian cells,” Neuroscience Letters, vol. 340, no. 3, pp. 234–238, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. M. D. Suh, C. H. Park, S. S. Kim et al., “Tissue transglutaminase is not involved in the aggregate formation of stably expressed α-synuclein in SH-SY5Y human neuroblastoma cells,” Archives of Pharmacal Research, vol. 27, no. 8, pp. 850–856, 2004. View at Google Scholar · View at Scopus